{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:19:11Z","timestamp":1793697551971,"version":"4.5.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Growing evidence argues for a relationship between liver and bone metabolisms. Sclerostin is a secreted glycoprotein and could antagonize osteoblast-mediated bone formation. Previous studies indicated that circulating sclerostin levels may be associated with metabolic parameters with inconsistent results. This study was designed to evaluate serum sclerostin in patients with or without nonalcoholic fatty liver disease (NAFLD) and to analyze its relationship with metabolic parameters in different populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was designed and 168 NAFLD subjects and 85 control subjects were included in this study. Serum sclerostin and metabolic parameters were measured. Mouse models of NAFLD were also induced by high-fat diet. Bone structural parameters were determined using microCT and mRNA expression levels of sclerostin in bone and liver tissues were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study suggested that circulating sclerostin levels were significantly lower in NAFLD subjects compared with normal controls. In NAFLD subjects, sclerostin was negatively correlated with multiple metabolic parameters, including waist circumference, urea, hepatic enzyme, gamma-glutamyl transpeptidase, and triglyceride, while such correlation was not significant in control subjects. Circulating sclerostin was also negatively correlated with fatty liver index in NAFLD subjects but not in control subjects. Mice fed on a high-fat diet had reduced bone mass and lower sclerostin expression levels in both the bone and liver tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study suggested that the liver-lipid-bone interactions may play a key role in the abnormal bone metabolism in NAFLD, and circulating sclerostin may be a surrogate marker to reflect bone metabolism status in NAFLD subjects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2021.707505","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T01:29:54Z","timestamp":1628126994000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Fangli","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5009\/gnl19069","article-title":"Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease","volume":"14","author":"Li","year":"2020","journal-title":"Gut Liver"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2017.01.008","article-title":"Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications","volume":"64","author":"Selvakumar","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-015-0687-x","article-title":"Circulating Sclerostin and Dickkopf-1 Levels in Patients With Nonalcoholic Fatty Liver Disease","volume":"34","author":"Polyzos","year":"2016","journal-title":"J Bone Miner Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic Complications of Nonalcoholic Fatty Liver Disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05196.x","article-title":"Review Article: Non-Alcoholic Fatty Liver Disease and Osteoporosis\u2013Clinical and Molecular Crosstalk","volume":"36","author":"Yilmaz","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04924.x","article-title":"Non-Alcoholic Fatty Liver Disease is Associated With Low Bone Mineral Density in Obese Children","volume":"35","author":"Pardee","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0528-3","article-title":"Association Between Bone Mineral Density and Nonalcoholic Fatty Liver Disease in Korean Adults","volume":"39","author":"Lee","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000535","article-title":"Association of Nonalcoholic Fatty Liver Disease With Bone Mineral Density and Serum Osteocalcin Levels in Korean Men","volume":"28","author":"Yang","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4257-z","article-title":"The Relationship Between Fatty Liver Index and Bone Mineral Density in Koreans: KNHANES 2010-2011","volume":"29","author":"Ahn","year":"2018","journal-title":"Osteoporos Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0342-3","article-title":"Association Between Nonalcoholic Fatty Liver Disease and Bone Mineral Density: A Systematic Review and Meta-Analysis","volume":"38","author":"Upala","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30538","article-title":"Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis","volume":"70","author":"Mantovani","year":"2019","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1888","article-title":"Correlates of Bone Microarchitectural Parameters and Serum Sclerostin Levels in Men: The STRAMBO Study","volume":"28","author":"Szulc","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1929","article-title":"Sclerostin and Bone Strength in Women in Their 10th Decade of Life","volume":"28","author":"Thorson","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1525-6","article-title":"Serum Sclerostin Levels Positively Correlate With Lumbar Spinal Bone Mineral Density in Postmenopausal Women\u2013The Six-Month Effect of Risedronate and Teriparatide","volume":"23","author":"Polyzos","year":"2012","journal-title":"Osteoporos Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02274","article-title":"Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults","volume":"103","author":"Napoli","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes","volume":"97","author":"Gennari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: A Simple and Accurate Predictor of Hepatic Steatosis in the General Population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.09.016","article-title":"Reduced Femoral Bone Mass in Both Diet-Induced and Genetic Hyperlipidemia Mice","volume":"93","author":"Chen","year":"2016","journal-title":"Bone"},{"key":"B20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bone.2016.11.024","article-title":"Sclerostin Expression and Functions Beyond the Osteocyte","volume":"96","author":"Weivoda","year":"2017","journal-title":"Bone"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1086\/318811","article-title":"Bone Dysplasia Sclerosteosis Results From Loss of the SOST Gene Product, A Novel Cystine Knot-Containing Protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e13695","DOI":"10.14814\/phy2.13695","article-title":"Circulating Sclerostin Is Not Suppressed Following a Single Bout of Exercise in Young Men","volume":"6","author":"Guerriere","year":"2018","journal-title":"Physiol Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S170533","article-title":"Novel Insights Into the Relationship Between Nonalcoholic Fatty Liver Disease and Osteoporosis","volume":"13","author":"Filip","year":"2018","journal-title":"Clin Interv Aging"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-1978-x","article-title":"Association of Serum Sclerostin With Bone Mineral Density, Bone Turnover, Steroid and Parathyroid Hormones, and Fracture Risk in Postmenopausal Women: The OFELY Study","volume":"24","author":"Garnero","year":"2013","journal-title":"Osteoporos Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s40610-017-0057-7","article-title":"Connecting Bone and Fat: The Potential Role for Sclerostin","volume":"3","author":"Fairfield","year":"2017","journal-title":"Curr Mol Biol Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25432","article-title":"Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells","volume":"117","author":"Ukita","year":"2016","journal-title":"J Cell Biochem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.10.001","article-title":"Association Between Non-Alcoholic Fatty Liver Disease and Bone Turnover Biomarkers in Post-Menopausal Women With Type 2 Diabetes","volume":"45","author":"Mantovani","year":"2019","journal-title":"Diabetes Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.707505\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T01:29:56Z","timestamp":1628126996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.707505\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":27,"alternative-id":["10.3389\/fendo.2021.707505"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.707505","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"article-number":"707505"}}